The Dobrobut medical network begins expansion in the regions, Ihor Mazepa, the founder and CEO of Concorde Capital, has said.
“The goal is to build a medical ATB. We are going beyond Kyiv and starting regional expansion,” he told Forbs.
Mazepa also said that capex for Dobrobut for the next five years will amount to $200-230 million.
He predicted that Dobrobut will earn $20 million of EBITDA in 2022 and the company’s value during this time “should grow to $200 million.”
“Dobrobut annually grows in sales by 40-45%. Our bet, which we placed on medicine five years ago, is beginning to be seriously paid off. I hope that after some time this business will cost more than $500 million,” he said.
In general, Mazepa estimates the Ukrainian medical market at $8 billion.
“The state still dominates in medicine. But the future belongs to private companies, and in five years they will come to the fore,” Mazepa said.
The Dobrobut medical network plans by 2020 to open a new medical building, investment in which would be around $20 million, Dobrobut Director General Oleh Kalashnikov said at a press conference at Interfax-Ukraine. “We are working on a new large building. Together with Philips, we have already developed a large conceptual project and approved a medical task for it,” he said.
Currently, a complete reconstruction of the building with an area of 9,600 square meters, located in Sevastopolska Square in Kyiv, is being held, repair works are under way.
According to the director general of Dobrobut, the medical service will be represented in three segments. “First of all, there will be a Center for Cardiovascular Diseases. We also plan to develop oncology and neurology in the building,” he said, adding that the new building will have five angiographic operating rooms.
At the same time, he said that the network intends to invest in angiography in the near future, which will allow Dobrobut to provide a full range of cardiosurgical services of all kinds, including endovascular ones.
“Regarding angiography and endovascular operations, I think that we will be able to do them in November and, accordingly, to cover the whole range of services,” he said, adding that the tender for the purchase of an angiograph is currently at the final stage.
Kalashnikov also said that since the opening of the Center for Cardiac Surgery early 2017, it has carried out a little more than 450 surgeries, 263 of which have been performed using a minimally invasive method.
In turn, Head of the center Oleksandr Babliak said that the center is the first among cardiosurgical clinics in the world, which began to implement multi-vessel coronary bypass surgeries using a minimally invasive method.
